Technical Data
B2671-11
8-Br-cGMP (8-Bromoguanosine-3', 5'-cyclic Monophosphate, Cyclic 8-bromoguanosine-3', 5'-monophosphate, 8-bromoguanosine-3', 5'-monophosphate)
5mg
|
Technical Data |
|
B2671-11 |
8-Br-cGMP (8-Bromoguanosine-3', 5'-cyclic Monophosphate, Cyclic 8-bromoguanosine-3', 5'-monophosphate, 8-bromoguanosine-3', 5'-monophosphate) |
5mg |
| Molecular Biology | Storage: -20°CShipping: Blue Ice |
|
A cell-permeable cGMP analog having greater resistance to hydrolysis by phosphodiesterases than cGMP. Activates cGMP-dependent protein kinase (PKG), slows or inhibits the intracellular calcium oscillations of tracheal smooth muscle cells in response to acetylcholine. It inhibits thrombin stimulated arachidonic acid release in human platelets. Solubility: H2O (~25mg/ml) or aqueous buffers Molecular Weight: ~446.08kD CAS Number: 51116-01-9 Molecular Formula: C H BrN O P. Na Molecular Weight: ~446.08kD |
Purity: ~95% (TLC) Concentration: Not determined Form: Supplied as a solid. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
|
||